Publications

5803 Results

A Phase II Study of Isatuximab (Sar650984) (Nsc-795145) for Patients with Previously Treated Al Amyloidosis (SWOG S1702; NCT#03499808)

Authors
T Parker;K Chansky;V Sanchorawala;H Landau;E Campagnaro;P Kapoor;N Neparidze;P Hagen;S Sarosiek;A Hoering;R Orlowski
Journal / Conference
International Symposium on Amyloidosis (virtual September 14-18, 2020, Tarragona, Spain), oral, #OP35
Year
2020
Research Committee(s)
Myeloma
Study Number(s)
S1702

Mendelian randomization analysis of n-6 polyunsaturated fatty acid levels and pancreatic cancer risk

Authors
D Ghoneim;J Zhu;W Zheng;J Long;H Murff;F Ye;P Goodman;D Albanes;C Fuchs;JM Gaziano;I Thompson;L Amundadottir;P Kraft;A Klein;R Stolzenberg-Solomon;X-O Shu;L Wu
Journal / Conference
Cancer Epidemiology Biomarkers & Prevention Dec;29(12):2735-2739
Year
2020
Research Committee(s)
Cancer Control, Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
PMID
PMID32967863
PMC
PMC8195110
Study Number(s)
S0000, SWOG-9217

IGF-binding proteins, adiponectin and survival in metastatic colorectal cancer: results from CALGB (Alliance)/SWOG 80405

Authors
B Guercio;S Zhang;F-S Ou;A Venook;D Niedzwiecki;H-J Lenz;F Innocenti;M Pollak;A Nixon;B Mullen;B O'Neil;J Shaw;B Polite;A Benson;J Atkins;R Goldberg;J Brown;EM O'Reilly;R Mayer;CD Blanke;C Fuchs;J Meyerhardt
Journal / Conference
JNCI Cancer Spectrum, Aug 27;5(1):pkaa074. doi: 10.1093/jncics/pkaa074. eCollection 2021 Feb.
Year
2020
Research Committee(s)
Gastrointestinal
PMID
PMID33426464
PMC
PMC7785047
Study Number(s)
CTSU/C80405

SWOG S1505: Initial Surgical Outcome Results from a Randomized Clinical Trial of mFOLFIRINOX vs. Gemcitabine/nab-Paclitaxel for Perioperative Treatment of Resectable Pancreatic Ductal Adenocarcinoma (PDA)

Authors
S Ahmad;M Duong;D Sohal;N Ghandi;MS Beg;A Wang-Gillam;J Wade;K Guthrie;A Lowy;PA Philip;H Hochster
Journal / Conference
American Surgical Association Annual Meeting (April 16-18, 2020, Washington, DC), oral presentation
Year
2020
Research Committee(s)
Gastrointestinal
Study Number(s)
S1505

When offered to participate: A systematic review and meta-analysis of patient agreement to participate in cancer clinical trials

Authors
J Unger;D Hershman;C Till;L Minasian;R Osarogiagbon;M Fleury;R Vaidya
Journal / Conference
J Clin Oncol 38, 2020 (suppl 29; abstr 92); ASCO Quality Care Symposium (October 9-10, 2020, Virtual), rapid abstract presentation
Year
2020
Research Committee(s)
Cancer Care Delivery

Trends in obesity among patients registered to SWOG cancer clinical treatment trials

Authors
R Vaidya;C Till;H Greenlee;D Hershman;J Unger
Journal / Conference
J Clin Oncol 38, 2020 (suppl 29; abstr 126); ASCO Quality Care Symposium (October 9-10, 2020, Virtual), poster
Year
2020
Research Committee(s)
Cancer Care Delivery

The Association of Patient Fatigue and Outcomes in Advanced Cancer: An Analysis of Four SWOG Treatment Trials

Authors
J Mo;A Darke;K Guthrie;J Sloan;J Unger;D Hershman;M O'Rourke;M Bakitas;R Krouse
Journal / Conference
J Clin Oncol 38, 2020 (suppl 29; abstr 140); ASCO Quality Care Symposium (October 9-10, 2020, Virtual), Rapid Abstract Presentation
Year
2020
Research Committee(s)
Genitourinary and Lung
Study Number(s)
S0027, S0421, SWOG-9509, S9916

A Hopefulness Survey of SWOG Members: Relationships among Hope, Job Stress, and Burnout

Authors
D Feldman;M O'Rourke;R Krouse;M Bakitas;H Deiniger;M Hudson;B Corn
Journal / Conference
J Clin Oncol 38, 2020 (suppl 29; abstr 185); ASCO Quality Care Symposium (October 9-10, 2020, Virtual), Rapid Abstract presentation
Year
2020

Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer

Authors
C Mackintosh;C Yuan;F-S Ou;S Zhang;D Niedzwiecki;I-W Chang;B O'Neil;B Mullen;H-J Lenz;CD Blanke;A Venook;R Mayer;C Fuchs;F Innocenti;A Nixon;R Goldberg;E O'Reilly;J Meyerhardt;K Ng
Journal / Conference
JAMA Oncology 2020 Sep 17;6(11):1713-1721. doi: 10.1001/jamaoncol.2020.3938. Online ahead of print.
Year
2020
Research Committee(s)
Gastrointestinal
PMID
PMID32940631
PMC
PMC7499248
Study Number(s)
CTSU/C80405

Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial

Authors
A Algazi;M Othus;A Daud;R Lo;J Mehnert;T-G Truong;R Conry;K Kendra;G Doolittle;J Clark;M Messino;D Moore;C Lao;B Faller;R Govindarajan;A Harker-Murray;L Dreisbach;J Moon;K Grossmann;A Ribas
Journal / Conference
Nature Medicine Oct;26(10):1564-1568. doi: 10.1038/s41591-020-1060-8. Epub 2020 Oct 5.
Year
2020
Research Committee(s)
Melanoma
PMID
PMID33020646
Study Number(s)
S1320